Prime Medicine Inc. (PRME) Social Stream
PRIME MEDICINE INC (PRME) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRME.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-15 | 4 | $27 | $22 | $24.25 | $17.58 | 37.94% |
| 2023-01-24 | 4 | $27 | $21 | $23.75 | $17.58 | 35.1% |
| NA | 4 | $NA | $NA | $NA | $17.58 | NA% |
PRME Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, PRIME MEDICINE INC's number of analysts covering the stock is higher than 47.94% of them.
- PRIME MEDICINE INC's variance in analysts' estimates is lower than 74.42% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, PRIME MEDICINE INC's upside potential (average analyst target price relative to current price) is greater than 51.1% of them.
- In terms of how PRIME MEDICINE INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 122.3% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PRIME MEDICINE INC are CDXC, MTEX, and MNMD.
View All Top Stocks by Price Target
What is the outlook for PRME? Use POWR Ratings for clearer insight into price direction.